Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2020 2
2021 3
2022 1
2023 1
2024 3
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy in nodal oligorecurrent prostate cancer.
Pinkawa M, Aebersold DM, Böhmer D, Flentje M, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Müller AC, Niehoff P, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T. Pinkawa M, et al. Strahlenther Onkol. 2021 Jul;197(7):575-580. doi: 10.1007/s00066-021-01778-1. Epub 2021 Apr 29. Strahlenther Onkol. 2021. PMID: 33914101 Free PMC article. Review.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Müller AC, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Niehoff P, Pinkawa M, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO). Müller AC, et al. Strahlenther Onkol. 2022 Aug;198(8):683-689. doi: 10.1007/s00066-022-01961-y. Epub 2022 Jun 15. Strahlenther Onkol. 2022. PMID: 35704054 Free PMC article. Review.
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).
Spohn SKB, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hoecht S, Hölscher T, Koerber SA, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Shelan M, Wolf F, Zamboglou C, Zips D, Wiegel T. Spohn SKB, et al. Strahlenther Onkol. 2025 Aug;201(8):759-766. doi: 10.1007/s00066-025-02388-x. Epub 2025 Mar 25. Strahlenther Onkol. 2025. PMID: 40131411 Free PMC article. Review.
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Wolf F, Sedlmayer F, Aebersold D, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Schmidt-Hegemann NS, Zamboglou C, Zips D, Wiegel T. Wolf F, et al. Strahlenther Onkol. 2021 Feb;197(2):89-96. doi: 10.1007/s00066-020-01723-8. Epub 2020 Dec 10. Strahlenther Onkol. 2021. PMID: 33301049 Free PMC article. Review.
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO).
Koerber SA, Höcht S, Aebersold D, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hölscher T, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zamboglou C, Zips D, Wiegel T. Koerber SA, et al. Strahlenther Onkol. 2024 Mar;200(3):181-187. doi: 10.1007/s00066-023-02193-4. Epub 2024 Jan 25. Strahlenther Onkol. 2024. PMID: 38273135 Free PMC article. Review.
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Sedlmayer F, Zips D, Wiegel T; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of the German Cancer Society (DKG-ARO). Ghadjar P, et al. Strahlenther Onkol. 2020 Jul;196(7):589-597. doi: 10.1007/s00066-020-01598-9. Epub 2020 Mar 12. Strahlenther Onkol. 2020. PMID: 32166452 Free PMC article. Review.
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Shelan M, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Schmidt-Hegemann NS, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T, Ghadjar P. Shelan M, et al. Strahlenther Onkol. 2021 Nov;197(11):993-1000. doi: 10.1007/s00066-021-01820-2. Epub 2021 Aug 31. Strahlenther Onkol. 2021. PMID: 34463814 Free PMC article.
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).
Zamboglou C, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hoecht S, Hölscher T, Koerber SA, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zips D, Wiegel T. Zamboglou C, et al. Strahlenther Onkol. 2025 Jan;201(1):4-10. doi: 10.1007/s00066-024-02288-6. Epub 2024 Aug 28. Strahlenther Onkol. 2025. PMID: 39196366 Free PMC article.
12 results